Most Recent
A class action on behalf of shareholders has been lodged against ASX-listed biotechnology company CSL over disclosures in relation to its forecast for the 2026 financial year.
Two law firms will battle for carriage of a shareholder class action against hearing device manufacturer Cochlear, a court has heard.
A judge said Tuesday a costs referee’s report did not give an “adequate basis” for $13 million in fees sought by a law firm behind a settled class action against Qantas over COVID-era flight cancellations.
A shareholder class action alleges Cochlear knew months before announcing a profit downgrade that weakening US demand, financial pressures on hospitals and problems with its new Nexa implant made its FY26 earnings guidance unreliable.
Hearing implant giant Cochlear faces a second shareholder class action following two forecast downgrades that wiped billions of dollars from the company's market value.
Hearing implant manufacturer Cochlear has been hit with a shareholder class action alleging its FY26 profit forecast failed to disclose challenges in its business.
A class action against Jetstar over flight cancellations during COVID-19 wants to add claims alleging the airline breached consumer guarantees and made intentionally false statements to hundreds of thousands of customers.
Construction PRO
James Hardie is facing another shareholder class action over the building materials company's representations to the market about its North American fibre cement business.
Class action settlements are off to a sluggish start in 2026, with only two mega-settlements of $100 million or more reached and the country's leading plaintiff law firm yet to get on the board.
Lawyers running a class action against Qantas over flight cancellations during COVID-19 will take home $15 million from a $105 million settlement, while the funder is set to receive another $25 million, a court has heard.